Vivanza Biosciences Ltd.BSE: VIVANZA

Outcome Of The Board Meeting And Submission Of Un-Audited Financial Results For The Quarter And Nine Months Ended 31ST December 2025

· Issued by Vivanza Biosciences Ltd. via BSE India

Pursuant to Regulation 30 and Regulation 33 of SEBI (LODR) Regulations, 2015 this is to inform you that the Board of Directors at its meeting held on Thursday, 12th February, 2026 has inter alia considered and approved the following:1. The Un-audited Financial results Standalone and Consolidated as per indian accounting Standards (IND AS) along with the Limited review Report (s) issued by the Statutory Auditor for the Quarter and Nine Months ended 31st December, 2025.The meeting of the Board of Directors of the Company commenced ot 2:30 P.M. and concluded at 3:00 P.M

View Attachment

View original source (BSE India)Vivanza Biosciences Ltd. on 6ix

Earlier from Vivanza Biosciences

Later from Vivanza Biosciences

All Vivanza Biosciences news releases